CD19 and breast cancer: Similarly, no significant differences were seen between non-BC and BC mice in terms of lineage reconstitution of the human cells engrafted, which mainly consisted of B cells (CD19+), myeloid cells (CD33+), or HSPCs (CD19−CD33−CD10−CD34+) (Fig. 3b).